相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjogren's Syndrome
Salome Glauzy et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Evolving epidemiology of HIV-associated malignancies
Meredith S. Shiels et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis
Florentin Spaeth et al.
CANCER RESEARCH (2017)
Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses
Fatemeh Saberi Hosnijeh et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts
Bryan A. Bassig et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Lag Times between Lympho-Proliferative Disorder and Clinical Diagnosis of Chronic Lymphocytic Leukemia: A Prospective Analysis Using Plasma Soluble CD23
Rudolf Kaaks et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies
Lauren R. Teras et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma
M. P. Purdue et al.
LEUKEMIA (2015)
Serum Levels of the Chemokine CXCL13, Genetic Variation in CXCL13 and Its Receptor CXCR5, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk
Shehnaz K. Hussain et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Serum Biomarkers of Immune Activation and Subsequent Risk of Non-Hodgkin B-Cell Lymphoma among HIV-Infected Women
Shehnaz K. Hussain et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
TLR2-Activated B Cells are Phenotypically Similar to the Abnormal Circulating B Cells Seen Preceding the Diagnosis of AIDS-Related NHL Diagnosis
Yu Guo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Increased T-Cell Activation and Th1 Cytokine Concentrations Prior to the Diagnosis of B-Cell Lymphoma in HIV Infected Patients
David Eric Ouedraogo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Jan Peveling-Oberhag et al.
JOURNAL OF HEPATOLOGY (2013)
Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma
Anneclaire J. De Roos et al.
CANCER RESEARCH (2012)
B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS-Associated Non-Hodgkin B-Cell Lymphoma
Elizabeth Crabb Breen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Differential Regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in Hepatitis C Virus-associated non-Hodgkin's Lymphoma
Zhi Q. Yao et al.
IMMUNOLOGICAL INVESTIGATIONS (2011)
Soluble IgE receptors-Elements of the IgE network
Barbara Platzer et al.
IMMUNOLOGY LETTERS (2011)
Systemic lupus erythematosus and increased risk to develop B cell malignancies: Role of the p200-family proteins
Sudhakar Veeranki et al.
IMMUNOLOGY LETTERS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia
B Saka et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2006)
Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge
DJ Amrol et al.
JOURNAL OF ASTHMA (2005)
B-cell activation and lymphoma in patients with HIV
O Martínez-Maza et al.
CURRENT OPINION IN ONCOLOGY (2002)
分享论文
